Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice
- 1 November 2000
- Vol. 19 (7-8) , 982-991
- https://doi.org/10.1016/s0264-410x(00)00213-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Regulation of cytokine gene expression by adjuvants in vivoClinical and Experimental Immunology, 1997
- Adjuvants influence the quantitative and qualitative immune response in
BALB c Vaccine, 1997 - Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virusJournal of General Virology, 1996
- Pathogenesis of Respiratory Syncytial Virus Vaccine-augmented PathologyAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Review of Polyclonal Antibody Production Procedures in Mammals and PoultryILAR Journal, 1995
- Economic impact of viral respiratory disease in childrenThe Journal of Pediatrics, 1994
- Distinct types of lung disease caused by functional subsets of antiviral T cells.The Journal of Experimental Medicine, 1994
- Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenonVaccine, 1993
- Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infectionJournal of General Virology, 1990
- Mechanism of lung injury in cotton rats immunized with formalin-inactivated respiratory syncytial virusVaccine, 1989